Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Everything we know about Mounjaro, new NHS weight loss jab
Weight-loss drug Mounjaro will help 'so many' people, say users
Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She started taking Mounjaro in May after struggling with weight gain following the birth of her two children. "I got to the stage where I went 'if this continues, I'm going to end up morbidly obese in my late 30s'," she said.
Everything we know about Mounjaro, the new NHS weight loss jab
Millions of NHS patients could wait 12 years for weight-loss drug Mounjaro, which rivals Ozempic and Wegovy. Although the injections will be given out from March, the health service is too overstretched to roll it out immediately.
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a magic bullet”.
NHS gets 12 years to roll out new weight-loss drug Mounjaro
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the NHS drugs advisory body says. The National Institute for Health and Care Excellence (NICE) final draft guidance on Mounjaro has recommended it starts being given from March, alongside advice on diet and exercise.
Mounjaro: NICE sets out £317m annual NHS weight loss jab rollout
The “first” NHS Mounjaro patients of a possible 3.4 million are set to receive the weight loss jab by March 2025, NICE has revealed in new draft guidance, while the first generic GLP-1 weight loss drug could soon follow.
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it?
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it? - Fewer than 10% of patients in England who are eligible will initially be able to access it on the NHS.
What is Mounjaro and how does it compare to other weight loss medications?
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that regulates insulin levels and appetite. When celebrities started shedding pounds with private prescriptions for the diabetes drug Ozempic,
11d
Mounjaro Lawsuits (2024 Update)
Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...
2d
on MSN
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...
FiercePharma
4d
For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access
Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
pharmaphorum
3d
Mounjaro cleared for NHS use, but patients may have to wait
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...
devdiscourse
4d
NICE Greenlights Mounjaro: A Milestone for Britain's Obesity Battle
NICE has recommended Eli Lilly's obesity drug Mounjaro for around 220,000 people in the UK via the state health system over ...
3d
Who can get new weight-loss jab Mounjaro on the NHS?
The rollout of the weight-loss drug to 3.4 million eligible patients could take up to 12 years, according to NICE.
Healthline
5d
Ozempic vs. Mounjaro: What You Should Know
Ozempic (semaglutide) and
Mounjaro
(tirzepatide) are prescription drugs used to manage type 2 diabetes. They can also help with weight loss. Both drugs are injected once per week. Ozempic and ...
1d
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Eli Lilly
Zepbound
Weight loss
India
England
Feedback